John S. Chapman Ph.D.
Dr. Chapman's career has been spent researching fundamental and applied aspects of antimicrobial agents, focusing on mechanisms of action, transport, and resistance development, particularly as they apply to biofilms. After a year studying plasmid biology of B. thuringiensis as a post-doc at the University of Georgia he spent two years as an NIH Infectious Diseases Fellow at the University of North Carolina Medical School. During this time he worked on the molecular genetics of Mycoplasma. Since transitioning to industry in 1986, he has been involved in antimicrobial agent discovery and development in both the antibiotics and biocide industries at Hoffman-LaRoche, Rohm and Haas, Proctor & Gamble, and DuPont.EducationDr. John S. Chapman earned a Ph.D. in microbial physiology from the University of California at Davis where he developed protocols to generate mutants of cyanobacteria. |
By this ResearcherRelated ContentTwo-Dimensional NanostructuresAfter the 2010 Nobel Prize in Physics was awarded to Andre Geim and Konstantin Novoselov "for groundbreaking experiments regarding the two-dimensional material graphene," even more research and development efforts have been focused on two-dimensional nanostructures. Illustrating the importance of this area in future applications, Two-Dimensional Nanostructures covers the fabrication methods and properties of these materials.
Researchers Build Optical Nanostructures To Enable Self-Focusing LightAn international team led by Columbia University’s Fu Foundation School of Engineering and Applied Science has built optical nanostructures that can control light dispersion and engineer the index of refraction. This control of light propagation via photonic chips could prove a major breakthrough for telecommunications.
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||
Now Online »
CRC Press — 2010 NanoScience and CleanTech catalog
